Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs dexmedetomidine for sedation during invasive mechanical ventilation weaning in severe pneumonia
ChiCTR2500103955Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Jining Medical University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and dexmedetomidine in pneumonia (2 arms), sponsored by Affiliated Hospital of Jining Medical University. Primary endpoint: Satisfaction rate of sedation. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
pneumonia
Beyond the preview
Go deeper on ChiCTR2500103955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103955.